Table 1

Comparisons of subject characteristics between evacuees and non-evacuees/temporary-evacuees

Baseline (2008–2010)2011201220132014
EvacueesNon-evacuees/temporary-evacueesEvacueesNon-evacuees/temporary-evacueesEvacueesNon-evacuees/temporary-evacueesEvacueesNon-evacuees/temporary-evacueesEvacueesNon-evacuees/temporary-evacuees
City of residence (N)
 Minamisoma9602818216832627192565720556171990
 Soma0262802038019610162501601
 Total96054462162870627388665736806173591
Demographic characteristics
 Age in years (mean, SD)62.0 (6.6)62.4 (7.1)64.9 (6.3)64.8 (7.3)65.3 (6.4)65.3 (6.9)65.5 (6.5)65.7 (6.6)66.0 (6.3)66.3 (6.3)
Gender (N, %)
 Male404 (41.9)2203 (40.5)95 (44.0)1169 (40.7)267 (42.6)1578 (40.6)281 (42.8)1459 (39.7)254 (41.2)1375 (38.3)
 Female556 (58.1)3243 (59.5)121 (56.0)1701 (59.3)360 (57.4)2308 (59.4)376 (57.2)2221 (60.4)363 (58.8)2216 (61.7)
Clinical characteristics (mean, SD)
 BMI (kg/m2)23.6 (3.2)23.5 (3.3)24.0 (3.4)23.6 (3.3)24.2 (3.3)***23.6 (3.4)***24.0 (3.3)**23.6 (3.4)**23.7 (3.4)*23.4 (3.4)*
 Systolic blood pressure (mm Hg)130.5 (16.1)130.7 (16.3)130.0 (14.6)131.7 (16.0)128.9 (15.5)*130.7 (16.2)*128.0 (14.6)128.7 (15.2)126.5 (14.1)**128.4 (14.8)**
 Diastolic blood pressure (mm Hg)77.5 (9.5)77.5 (9.7)78.0 (11.3)79.0 (10.2)76.7 (10.2)76.9 (10.3)76.3 (9.2)75.7 (9.8)74.6 (9.3)75.1 (9.6)
 HbA1c (%)5.5 (0.6)5.5 (0.6)5.4 (0.5)5.5 (0.6)5.6 (0.5)5.6 (0.6)5.7 (0.6)5.7 (0.6)5.6 (0.6)5.6 (0.6)
 HDL-C (mg/dL)61.4 (14.4)61.4 (14.8)59.8 (14.5)60.9 (14.7)56.2 (13.2)***58.8 (14.3)***57.9 (13.9)**59.6 (14.3)**58.1 (13.8)***60.3 (14.8)***
 LDL-C (mg/dL)124.9 (30.0)125.4 (31.0)126.5 (30.9)124.4 (31.1)120.0 (31.1)122.2 (31.0)123.5 (30.5)124.8 (31.0)121.0 (29.7)**124.8 (31.2)**
 ALT/GPT (IU/L)22.0 (13.3)22.7 (18.5)23.3 (16.5)24.7 (17.7)24.2 (16.4)23.4 (18.2)23.0 (16.6)22.1 (19.3)22.8 (16.4)22.1 (14.6)
 AST/GOT (IU/L)24.8 (11.5)25.1 (11.9)24.8 (8.7)26.4 (15.0)26.4 (13.9)25.7 (12.2)25.1 (12.2)24.9 (15.6)24.6 (10.9)24.8 (14.7)
 γ-GTP (IU/L)34.0 (40.9)37.4 (51.4)35.8 (42.4)39.3 (56.7)38.6 (43.8)36.6 (44.9)36.8 (51.2)36.4 (56.4)34.5 (63.7)35.8 (55.2)
 Urine protein (N, % of positive)16 (1.7)115 (2.1)3 (1.4)58 (2.0)6 (1.0)64 (1.7)13 (2.0)59 (1.6)8 (1.3)68 (1.9)
 Urine occult blood (N, % of positive)55 (5.7)319 (5.9)20 (9.3)209 (7.6)17 (2.7)*184 (4.8)*30 (4.6)185 (5.1)30 (4.9)163 (4.6)
 Urine glucose (N, % of positive)19 (2.0)130 (2.4)2 (0.9)60 (2.1)8 (1.3)89 (2.3)10 (1.5)74 (2.0)14 (2.3)68 (1.9)
Medical characteristics of interests (N, %)
Presence of diseases
 Diabetes74 (7.7)415 (7.7)20 (9.3)226 (8.0)64 (10.2)368 (9.5)86 (13.1)423 (11.6)84 (13.6)399 (11.2)
 Hyperlipidaemia430 (44.8)2390 (44.3)109 (50.5)1290 (45.2)336 (53.6)**1815 (46.8)**394 (60.0)***1877 (51.2)***341 (55.3)1874 (52.6)
 Hypertension437 (45.5)2463 (45.3)112 (51.9)1506 (52.6)333 (53.1)2020 (52.1)366 (55.7)*1888 (51.3)*297 (48.1)1758 (49.2)
  • *p<0.05, **p<0.01, ***p<0.001 for evacuees versus non-evacuees/temporary-evacuees: Un-paired t test for continuous outcomes and χ2 test for categorical outcomes.

  • ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; GOT, glutamic oxaloacetic transaminase; GPT, glutamic pyruvic transaminase; HbA1c, glycated haemoglobin; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.